ArticleACG case reports journal2024

Efficacy of Ustekinumab Intravenously q12 Weeks for Maintenance Therapy for Crohn's Disease.

Hamza Masood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.